FDA approves first drug for tardive dyskinesia
On April 11, the U.S. Food and Drug Administration (FDA) approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. It’s the first drug approved by the FDA…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
